Nurix Therapeutics Stock (NASDAQ: NRIX) stock price, news, charts, stock research, profile.
Open | $24.10 |
Close | $24.02 |
Volume / Avg. | 436.74K / 937.49K |
Day Range | $22.84 - $24.35 |
52 Wk Range | 4.22 - 24.54 |
Market Cap | $1.55B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 64 |
Short Interest | 15.64% |
Days to Cover | 13.23 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Nurix Therapeutics (NASDAQ:NRIX) through any online brokerage.
Other companies in Nurix Therapeutics’s space includes: ARS Pharmaceuticals (NASDAQ:SPRY), Centessa Pharmaceuticals (NASDAQ:CNTA), Syndax Pharmaceuticals (NASDAQ:SNDX), Prothena Corp (NASDAQ:PRTA) and Immatics (NASDAQ:IMTX).
Nurix Therapeutics has a consensus price target of $26.79.
The stock price for Nurix Therapeutics (NASDAQ: NRIX) is $24.02 last updated August 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Nurix Therapeutics.
Nurix Therapeutics’s Q3 earnings are confirmed for Thursday, October 10, 2024.
There is no upcoming split for Nurix Therapeutics.
Nurix Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.